Performance characteristics between TDx®FLx and TBA™-25FR for the therapeutic drug monitoring of methotrexate

BACKGROUND: High-dose methotrexate (HDMTX) is used in the treatment of certain malignancies, including leptomeningeal metastases, systemic non-Hodgkin lymphoma, acute lymphoblastic leukemia, and osteosarcoma. High circulating levels of methotrexate can cause severe myelosuppression. The present stud...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pharm Health Care Sci
Hlavní autoři: Kaneko, Tetsuya, Fujioka, Takashi, Suzuki, Yosuke, Sato, Yuhki, Itoh, Hiroki
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Short Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4782285/
https://ncbi.nlm.nih.gov/pubmed/26958349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-016-0042-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky